Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.

MLA

Morales-Oyarvide, Vicente, et al. “Lymph Node Metastases in Resected Pancreatic Ductal Adenocarcinoma: Predictors of Disease Recurrence and Survival.” British Journal of Cancer, vol. 117, no. 12, Dec. 2017, pp. 1874–82. EBSCOhost, https://doi.org/10.1038/bjc.2017.349.

APA

Morales-Oyarvide, V., Rubinson, D. A., Dunne, R. F., Kozak, M. M., Bui, J. L., Yuan, C., Qian, Z. R., Babic, A., Da Silva, A., Nowak, J. A., Khalaf, N., Brais, L. K., Welch, M. W., Zellers, C. L., Ng, K., Chang, D. T., Miksad, R. A., Bullock, A. J., Tseng, J. F., … Wolpin, B. M. (2017). Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. British Journal of Cancer, 117(12), 1874–1882. https://doi.org/10.1038/bjc.2017.349

Chicago

Morales-Oyarvide, Vicente, Douglas A Rubinson, Richard F Dunne, Margaret M Kozak, Justin L Bui, Chen Yuan, Zhi Rong Qian, et al. 2017. “Lymph Node Metastases in Resected Pancreatic Ductal Adenocarcinoma: Predictors of Disease Recurrence and Survival.” British Journal of Cancer 117 (12): 1874–82. doi:10.1038/bjc.2017.349.